Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars.

Alannah QuinlivanSusan LesterClaire BarrettSamuel Lawrance Whittle Debra Rowett Rachel J BlackVibhasha ChandFranca Marine Lyn March Premarani Sinnathurai Rachelle Buchbinder Catherine L Hill

Published in: Rheumatology advances in practice (2022)

Australian patients have positive attitudes towards b/tsDMARDs overall, although little knowledge of biosimilars specifically. They have a high degree of trust in their rheumatologist regarding treatment decisions, even if they are unfamiliar with the medication recommended.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
oxidative stress
prognostic factors
stem cells
mental health
emergency department
bone marrow
cell therapy
adverse drug
electronic health record